BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1648716)

  • 1. Effect of the bombesin receptor blockers [Leu13, psi CH2NH-Leu14]bombesin and N-pivaloyl GRP(20-25) alkylamide (L 686,095-001C002) on basal and neuromedin C-stimulated PRL and GH release in pituitary cell aggregates.
    Houben H; Denef C
    Peptides; 1991; 12(2):371-4. PubMed ID: 1648716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of growth hormone and prolactin release from rat pituitary cell aggregates by bombesin- and ranatensin-like peptides is potentiated by estradiol, 5 alpha-dihydrotestosterone, and dexamethasone.
    Houben H; Denef C
    Endocrinology; 1990 May; 126(5):2257-66. PubMed ID: 2328688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for the presence of gastrin-releasing peptide immunoreactivity in rat anterior pituitary corticotrophs and lactotrophs, AtT20 cells, and GH3 cells: failure to demonstrate participation in local control of hormone release.
    Houben H; Denef C
    Endocrinology; 1991 Jun; 128(6):3208-18. PubMed ID: 1645264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative regulation by dexamethasone of the potentiation of neuromedin C-induced growth hormone and prolactin release by estradiol in anterior pituitary cell aggregates.
    Houben H; Denef C
    Life Sci; 1992; 50(11):775-80. PubMed ID: 1740962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unexpected effects of peptide and nonpeptide substance P receptor antagonists on basal prolactin and growth hormone release in vitro.
    Houben H; Denef C
    Peptides; 1993; 14(1):109-15. PubMed ID: 7680128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine effects of new bombesin/gastrin-releasing peptide antagonists in rats.
    Pinski J; Yano T; Groot K; Cai RZ; Radulovic S; Schally AV
    Am J Physiol; 1992 Oct; 263(4 Pt 1):E712-7. PubMed ID: 1415689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological effects and receptor binding affinities of new pseudononapeptide bombesin/GRP receptor antagonists with N-terminal D-Trp or D-Tpi.
    Radulovic S; Cai RZ; Serfozo P; Groot K; Redding TW; Pinski J; Schally AV
    Int J Pept Protein Res; 1991 Dec; 38(6):593-600. PubMed ID: 1726427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bombesin, neuromedin B and neuromedin C interact with a common rat pancreatic phosphoinositide-coupled receptor, but are differentially regulated by guanine nucleotides.
    Sekar MC; Uemura N; Coy DH; Hirschowitz BI; Dickinson KE
    Biochem J; 1991 Nov; 280 ( Pt 1)(Pt 1):163-9. PubMed ID: 1720612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [D-Ala1, Leu9-psi-CH2NH-Leu10]neuromedin C antagonizes neuromedin C-stimulated amylase release by acini isolated from the rat pancreas.
    Wisner JR; Xue BG; Coy DH; Renner IG
    Pancreas; 1990 Jul; 5(4):408-14. PubMed ID: 1696379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a new bombesin receptor antagonist, (E)-alkene bombesin isostere, on amylase release from rat pancreatic acini.
    Wada M; Doi R; Hosotani R; Higashide S; Ibuka T; Habashita H; Nakai K; Fujii N; Imamura M
    Pancreas; 1995 Apr; 10(3):301-5. PubMed ID: 7542772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-chain pseudopeptide bombesin receptor antagonists with enhanced binding affinities for pancreatic acinar and Swiss 3T3 cells display strong antimitotic activity.
    Coy DH; Taylor JE; Jiang NY; Kim SH; Wang LH; Huang SC; Moreau JP; Gardner JD; Jensen RT
    J Biol Chem; 1989 Sep; 264(25):14691-7. PubMed ID: 2475489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial agonist activity of the bombesin-receptor antagonist [Leu14-psi-CH2-NH-Leu13]-bombesin in frog peptic cells.
    Dickinson KE; Uemura N; Sekar MC; McDaniel HB; Anderson W; Coy DH; Hirschowitz BI
    Biochem Biophys Res Commun; 1988 Dec; 157(3):1154-8. PubMed ID: 2462868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Leu13-psi(CH2NH)Leu14]bombesin is a specific bombesin receptor antagonist in Swiss 3T3 cells.
    Woll PJ; Coy DH; Rozengurt E
    Biochem Biophys Res Commun; 1988 Aug; 155(1):359-65. PubMed ID: 2843183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the neurotransmitter/neuromodulator functions of the neuropeptide gastrin-releasing peptide in the porcine antrum, using the antagonist (Leu13-psi-CH2 NH-Leu14)-bombesin.
    Holst JJ; Harling H; Messell T; Coy DH
    Scand J Gastroenterol; 1990 Jan; 25(1):89-96. PubMed ID: 1968286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of BIM26226, a potent and specific bombesin receptor antagonist, on amylase release and binding of bombesin-like peptides to AR4-2J cells.
    Dietrich JB; Hildebrand P; Jeker LB; Pansky A; Eberle AN; Beglinger C
    Regul Pept; 1994 Oct; 53(3):165-73. PubMed ID: 7531356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A potent bombesin receptor antagonist inhibits bombesin-stimulated growth of mouse colon cancer cells in vitro: absence of autocrine effects.
    Narayan S; Spindel ER; Rubin NH; Singh P
    Cell Growth Differ; 1992 Feb; 3(2):111-8. PubMed ID: 1323998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of nitric oxide in the interferon-gamma-induced inhibition of growth hormone and prolactin secretion in anterior pituitary cell cultures.
    Vankelecom H; Matthys P; Denef C
    Mol Cell Endocrinol; 1997 May; 129(2):157-67. PubMed ID: 9202399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bombesin stimulates prolactin and growth hormone release by pituitary cells in culture.
    Westendorf JM; Schonbrunn A
    Endocrinology; 1982 Feb; 110(2):352-8. PubMed ID: 6799271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Verapamil: influence upon basal and stimulated rat growth hormone and prolactin release in vitro.
    Stachura ME
    Proc Soc Exp Biol Med; 1983 May; 173(1):109-17. PubMed ID: 6134290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of bombesin, gastrin-releasing peptide (GRP)(14-27) and bombesin/GRP receptor antagonist RC-3095 on growth of nitrosamine-induced pancreatic cancers in hamsters.
    Szepeshazi K; Schally AV; Groot K; Halmos G
    Int J Cancer; 1993 May; 54(2):282-9. PubMed ID: 8387464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.